Bambuterol

This MedLibrary.org supplementary page on Bambuterol is provided directly from the open source Wikipedia as a service to our readers. Please see the note below on authorship of this content, as well as the Wikipedia usage guidelines. To search for other content from our encyclopedia supplement, please use the form below:

Bambuterol
Systematic (IUPAC) name
{3-(dimethylcarbamoyloxy)-5-[1-hydroxy-2-(tert-butylamino)
ethyl]phenyl} N,N-dimethylcarbamate
Identifiers
CAS number 81732-46-9
ATC code R03CC12
PubChem 54766
Chemical data
Formula C18H29N3O5 
Mol. mass 367.44 g/mol
Pharmacokinetic data
Bioavailability 20%
Metabolism Hepatic, extensive
Further metabolized to terbutaline by plasma cholinesterase
Half life 13 hours (bambuterol)
21 hours (terbutaline)
Excretion Renal
Therapeutic considerations
Pregnancy cat.

Unknown

Legal status

Prescription only

Routes Oral

Bambuterol (INN, marketed by AstraZeneca under the trade names Bambec and Oxeol) is a long acting beta-adrenoceptor agonist used in the treatment of asthma. It is a prodrug of terbutaline.


Wikipedia content modification information:

  • This page was last modified on 19 July 2008, at 21:18.

Wikipedia Authorship and Review

Wikipedia content provided here is not reviewed directly by MedLibrary.org. Wikipedia content is authored by an open community of volunteers and is not produced by or in any way affiliated with MedLibrary.org.

Wikipedia Usage Guidelines

This article is licensed under the GNU Free Documentation License. It uses material from the Wikipedia article on "Bambuterol".

The URL for this specific entry is:

All Wikipedia text is available under the terms of the GNU Free Documentation License. (See Copyrights for details). Wikipedia® is a registered trademark of the Wikimedia Foundation, Inc.